Our findings provide new insights into the roles of USP8 in Wnt/β-catenin signaling pathway, and reveals a potential therapeutic strategy to utilize a USP8 inhibitor for HCC treatment. This evidence concerns the gene USP8 and hepatocellular carcinoma.